Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Peritoneal Neoplasms 2Hepatoblastoma 2Testicular Neoplasms 1Seminoma 1Ovarian Neoplasms 1Ototoxicity 1Neoplasms, Germ Cell and Embryonal 1Necrosis 1Medulloblastoma 1Hearing Loss 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Cyclophosphamide 14Temozolomide 11Vincristine 9Magnetic Resonance Spectroscopy 9Cisplatin 9Etoposide 8Specimen Handling 7Radiotherapy 7X-Rays 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Lomustine 5Carboplatin 5Methotrexate 4Irinotecan 4Biopsy 4etoposide phosphate 3Thiotepa 3Radiation 3Platinum 3Nivolumab 3Filgrastim 3Celecoxib 3Bevacizumab 3Automobiles 31,2-diaminocyclohexaneplatinum II citrate 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × sodium thiosulfate × 1 year × Clear all
NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡